Pyxis Oncology (PYXS) to Acquire Apexigen (APGN) for $0.64/s

Pyxis Oncology (PYXS) to Acquire Apexigen (APGN) for $0.64/sh

Pyxis Oncology (PYXS) to Acquire Apexigen (APGN) for $0.64/sh
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

United States , American , Wilson Sonsini Goodrich Rosati , Jan Pinkas , Xiaodong Yang , Jaym Feingold , Pamela Connealy , Laras Sullivan , Novarti Beovu , Contactjennifer Davis Ruffvice , Twitter , Apexigen Contactwilliam Dukechief Financial Officerapexigen Inc , Pfizer , Novartis , Ladenburg Thalmann Co , Linkedin , American Society Of Clinical Oncology , Apexigen Inc , Flexible Antibody Conjugation Technology , Legal Advisors Sidley Austin , Nasdaq , Pyxis Oncology Inc , Exchange Commission , Pyxis Oncology , Chief Executive Officer , Clinical Oncology , Chief Medical Officer , Oncology Conference Call , Closing Operations , Leadership Effective , Chief Financial Officer , Chief Operating Officer , Chief Scientific , Ladenburg Thalmann , Wilson Sonsini Goodrich , Mutation Lineage Guided , Inc Pyxis Oncology , Looking Statements This , Private Securities Litigation Reform Act , Annual Report , Quarterly Report , Additional Information Will Be Filed , Registration Statement , Proxy Statement , Solicitationpyxis Oncology , Oncology Contactjennifer Davis Ruffvice President ,